We will be exhibiting at the Bio Pharmaceutical EXPO.

Over 80 years of experience! Introducing our three main products: domestically produced peptone and extracts!

We would like to introduce our three main products in the "Pepton and Extracts" category. The pepton derived from milk casein digested with pancreatin, "Far East Pepton (fine granules)," demonstrates high growth-supporting power for the cultivation of general bacteria and for use in fermentation industries. Additionally, we offer "Far East Potato Pepton CP," which is made from potato protein digested with bacterial enzymes, and "Far East Powdered Yeast Extract," which is produced by self-dissolving yeast and drying the soluble components. We also have other products available. 【Main 3 Products】 ■ Far East Pepton (fine granules) ■ Far East Potato Pepton CP ■ Far East Powdered Yeast Extract *For more details, please refer to the PDF document or feel free to contact us.

• Culture medium
• Bio-related synthesis and fermentation
• Other bio-related products

Optimized as a dispersion solution for human iPS/ES cells!

It has been demonstrated that using it in combination with "CP-5E" for the cryopreservation of human iPS/ES cells results in a high survival rate after thawing. Due to its broad substrate specificity and ability to degrade various proteins, it can also be applied to other uses. 【Features】 ■ Usable for both on-feeder and feeder-free cultures ■ Capable of adjusting the dispersion state from single cells to uniform cell aggregates ■ Ready-to-Use ■ Free from animal-derived materials *Please contact us if you would like a sample. *For more details, please contact us or refer to the catalog.

• Other research reagents
• Other bio-related products and services

Over 40 years of experience and reliability! We will produce culture media according to your specified composition.

At Kyokuto Pharmaceutical Industrial Co., Ltd., we manufacture media with specified compositions for biopharmaceutical production, regenerative medicine, vaccine production, and more. 【Features】 ■ Over 40 years of trust and experience ■ Excellent grinding technology ■ Traceability of raw materials ■ Thorough manufacturing and quality control *For more details, please refer to the catalog or feel free to contact us.

• Culture medium
• Other bio products
• OEM

This is a cryopreservation solution suitable for slow freezing of human iPS/ES cells!

By combining it with the cell dispersion solution "Pronase/EDTA for Stem," a high survival rate can be achieved. The composition is clear, so you can use it with confidence. 【Features】 ■ Enables cryopreservation of various cells, including human iPS/ES cells ■ Usable for human iPS cells cultured without feeders ■ Allows cryopreservation with a small number of cells ■ Reduces differentiation risk by keeping DMSO concentration at 5% ■ Free from animal-derived materials 【Examples of cells that can be preserved with CP-5E】 ■ Human iPS cell lines (253G1, 201B7*) ■ Human ES cell lines (KhES-1*, H1) ■ Mouse adipocyte precursor cell line (3T3-L1*) ■ Human pancreatic cancer cell line (PANC-1) ■ Primate kidney-derived cell line (COS-7) ■ Human fetal lung-derived fibroblast cell line (WI-38) ■ Human fetal lung-derived fibroblast cell line (MRC-5) ■ Human fetal kidney-derived cells (HEK-293) ■ Mouse feeder cells (SNL76/7) ■ Human myeloid leukemia cell line (HL-60*) ■ Human NK cell line (NK-92MI) (* Differentiation ability confirmed after freezing and thawing) *For more details, please contact us or refer to the catalog.

• Other research reagents
• reagent
• Other bio-related products and services

From February 11 (Wednesday) to February 13 (Friday), Mikasa Trading Co., Ltd. will sponsor the technology conference "JANOG57 Meeting in Osaka" held at the Congre Convention Center. This event provides an open platform for field engineers to freely discuss and share the latest network technologies, practical operational know-how, and case studies of failures. This time, we will be exhibiting a booth in collaboration with Western Digital Marketing LLC, showcasing innovative storage solutions such as the "Ultrastar Data60" and HDDs with a maximum capacity of 30TB. The Ultrastar Data60 is recognized for its ability to efficiently accommodate up to 60 high-quality HDDs while achieving large capacity, low cost, and space-saving design. Additionally, we will display mobile label printers made by Brady Japan at our booth. You will have the opportunity to see products that are actively used in infrastructure development and data management up close. Don't miss this chance to experience the technologies that support the future! We look forward to seeing you at the venue.

Cancer Biomarker Discovery 2026 is an online seminar focused on the latest biomarker discovery and analysis technologies in the field of cancer research. Advanced technologies that support the understanding, diagnosis, and treatment research of cancer, such as liquid biopsy, proteomics, and spatial omics analysis, will be introduced. This seminar primarily targets basic and clinical researchers involved in cancer research, as well as those interested in biomarker discovery and analysis. In our section, we will introduce the latest techniques in fluorescent imaging for spatial biology and spatial proteomics research, centered around the Invitrogen EVOS S1000 Spatial Imaging System. Unlike traditional microscopy, which is limited in multiplex immunostaining, our spectral unmixing technology enables simultaneous imaging of up to 9 colors, allowing for rapid data acquisition with minimized sample damage. Additionally, we will explain a practical workflow using direct conjugate antibodies and TSA-based Invitrogen Aluora amplification reagents, proposing high-reproducibility analysis methods that leverage spatial information. For research use only. Not for diagnostic use.

In spatial biology/spatial proteomics research, the coexistence of "high-quality multiplex fluorescence image acquisition" and "reliable quantitative analysis" is becoming increasingly important. This webinar, co-hosted by Thermo Fisher Scientific and Indica Labs, will introduce a practical workflow that allows for a comprehensive understanding from imaging to analysis. Recommended for: - Those interested in spatial biology/spatial proteomics research who want to systematically understand the entire process from imaging to analysis. - Those who are already conducting or considering the implementation of multiplex imaging (multiplex immunostaining). - Those who feel limited by traditional four-color fluorescence observation and wish to engage in higher-dimensional spatial information analysis. This is a free seminar, so please join us. *For research use only. Not for diagnostic use.

[Speaker] Naoki Eguchi, Attorney at Baker McKenzie [Lecture Topics] 1. Utilization of Storage Batteries (1) Storage Batteries for Renewable Energy Integration (2) Grid-Side Storage Batteries (3) Hybrid Power Generation with Solar, Wind, and Storage Batteries 2. Positioning of Grid-Side Storage Batteries 3. Subsidies for Grid-Side Storage Batteries / Long-Term Decarbonization Power Source Auctions 4. Practical Aspects and Contracts for Grid-Side Storage Batteries - Offtake Model, Merchant Model 5. Current Status of Corporate PPAs (Overseas and Japan) 6. Types of Corporate PPAs (Physical and Virtual) 7. Contracts for Corporate PPAs 8. Corporate PPAs and Project Finance 9. Q&A / Business Card Exchange

[Instructor] Professor at Waseda University Graduate School of Political Science and Economics / Director of the Institute for Environmental Economic Management Visiting Researcher at Sciences Po Paris Faculty Fellow at the National Institute of Economic and Industrial Research Mr. Toshihide Arimura [Key Lecture Content] Starting in the fiscal year 2026, participation in the GX-ETS will become mandatory for some companies in Japan. Carbon costs will become an increasingly important factor in considering long-term value creation for businesses. This seminar will explain the impacts of the full-scale implementation of the GX-ETS on Japanese companies and the economy. Additionally, we will introduce the future outlook for the GX-ETS and the paths that should be taken, from the perspectives of comparison with overseas emissions trading systems and its economic significance.